Consistent with the protumor role of chronic inflammation, interleukin (IL)-1 beta, IL-6, and IL-8 expressed in oral potentially malignant disorders (OPMDs) increase when the latter evolve into oral squamous cells carcinoma (OSCC) and, even more, when OSCC metastasizes. The gene discussed is IL6; the disease is oral cavity squamous cell carcinoma.